Glenmark moves up on receiving USFDA's approval for generic version of Loestrin

07 Jun 2018 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 538.10, up by 2.15 points or 0.40% from its previous closing of Rs. 535.95 on the BSE.

The scrip opened at Rs. 548.75 and has touched a high and low of Rs. 548.75 and Rs. 534.00 respectively. So far 12387 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 748.00 on 28-Jul-2017 and a 52 week low of Rs. 483.60 on 30-May-2018.

Last one week high and low of the scrip stood at Rs. 548.75 and Rs. 513.10 respectively. The current market cap of the company is Rs. 15143.96 crore.

The promoters holding in the company stood at 46.54%, while Institutions and Non-Institutions held 37.37% and 16.10% respectively.

Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval from the United States Food & Drug Administration (USFDA) for HAILEY 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1.5 mg/30 mcg), the generic version of Loestrin 21 1.5/30 Tablets, of Allergan Pharmaceuticals International (Allergan) and for HAILEY Fe 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets, 1.5 mg/30 mcg), the generic version of Loestrin Fe 1.5/30, also of Allergan.

According to IQVIA sales data for the 12 month period ending April 2018, the Loestrin 21 1.5/30 Tablets market achieved annual sales of around $24.2 million and the Loestrin Fe 1.5/30 market achieved annual sales of around $41.3 million.

Glenmark’s current portfolio consists of 137 products authorized for distribution in the US marketplace and 61 ANDAs pending approval with the USFDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Glenmark Pharma Share Price

2016.90 30.15 (1.52%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×